DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr. Reddy's Laboratories
02 1Granules India Limited
03 1ANDAS 5 HOLDING
04 1Actavis Inc
05 1Appco Pharmaceutical Corp
06 1Aurobindo Pharma Limited
07 1Micro Labs Limited
08 1Takeda Pharmaceutical
09 1Xiromed
10 1Zydus Pharmaceuticals
11 1i3 Pharmaceuticals
Reset all filters
01 11TABLET;ORAL
Reset all filters
01 11RX
Reset all filters
01 10RAMELTEON
02 1ROZEREM
Reset all filters
01 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2013-07-26
Application Number : 91693
Regulatory Info : RX
Registration Country : USA
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2020-08-21
Application Number : 213186
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2015-08-19
Application Number : 91610
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2020-10-26
Application Number : 213815
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-07-10
Application Number : 215972
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2020-04-10
Application Number : 212650
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2023-02-09
Application Number : 215243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ROZEREM
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2005-07-22
Application Number : 21782
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2022-11-25
Application Number : 216209
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2019-07-22
Application Number : 211567
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAMELTEON
Dosage Form : TABLET;ORAL
Dosage Strength : 8MG
Packaging :
Approval Date : 2022-08-24
Application Number : 215435
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF